Lai, Peilong
Chen, Xiaomei
Guo, Liyan
Wang, Yulian
Liu, Xialin
Liu, Yan
Zhou, Tian
Huang, Tian
Geng, Suxia
Luo, Chengwei
Huang, Xin
Wu, Suijing
Ling, Wei
Du, Xin
He, Chang
Weng, Jianyu
Funding for this research was provided by:
National Key R&D Program of China (2018YFA0108300)
National Natural Science Foundation of China (81700825, 81300446 and 81870508, 81370665, 81270648 and 81671585)
Guangdong Science and Technology Department (2014B020226002, 2015B020227003 and 2015B020226001, 2017B020230004 and 2014B020212009)
Science and Technology Planning Project of Guangzhou, China (201400000003-4, 201803040005 and 201803040011)
Natural Science Foundation of Guangdong Province (S2013030013305)
Article History
Received: 10 October 2018
Accepted: 21 November 2018
First Online: 7 December 2018
Ethics approval and consent to participate
: All the animal experimental design and procedures were reviewed and approved by the animal experimental ethics committee of Guangdong General Hospital. Human PBMCs from patients with active cGVHD were obtained with informed consent for research purposes, and the procedures were approved by the Ethics Committees of Guangdong General Hospital. Consent to publish has been obtained from the participant to report individual patient data.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.